Try our Advanced Search for more refined results

August 07, 2014

MERCK SHARP & DOHME CORP. v. FRESENIUS KABI USA, LLC

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 31, 2016

    Generic Drug Co. Can't Kill Merck IP Suit Over Antifungal

    A New Jersey federal judge ruled Monday that Merck & Co. Inc. has a valid patent covering fungal infection treatment Cancidas, allowing a patent infringement suit the drug giant lodged against generic drugmaker Fresenius Kabi USA LLC to move forward.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!